...
首页> 外文期刊>Renal failure. >Long-term quality of life and hospital mortality in patients treated with intermittent or continuous hemodialysis for acute renal and respiratory failure.
【24h】

Long-term quality of life and hospital mortality in patients treated with intermittent or continuous hemodialysis for acute renal and respiratory failure.

机译:间歇性或连续性血液透析治疗急性肾功能衰竭和呼吸衰竭的患者的长期生活质量和医院死亡率。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To describe long-term quality of life, intensive care, and hospital mortality in patients with acute renal and respiratory failure treated with one of two methods of renal replacement therapy (RRT). DESIGN: Cross-sectional survey of long-term survivors from a prospective observational study of two methods of RRT. SETTING: A combined surgical and medical intensive care unit in a university hospital. PATIENTS AND PARTICIPANTS: One hundred and twenty-six patients with acute renal and respiratory failure who required treatment with RRT and mechanical ventilation. Interventions. (1) RRT for acute renal failure was with either continuous hemodialysis with ultrafiltration using biocompatible membranes and prostacyclin and heparin anticoagulation (CHDF) or intermittent hemodialysis using cuprophane membranes and heparin anticoagulation (IHD); (2) Health-related quality of life in long-term survivors was assessed with the SF-36 (HRQL) questionnaire. MEASUREMENTS AND MAIN RESULTS: (1) There was no difference in ICU mortality (73.5% [39/53] IHD vs. 71.8% [46/64] CHDF, P = NS) or hospital mortality (83% [44/53] IHD vs. 76.5% [49/64] CHDF, P = NS) between the two RRT treatment groups. By 1999, there were 16 surviving patients; (2) Twelve of these survivors completed SF-36 forms (10 CHDF vs. 2 IHD). The overall physical health summary score and scores for seven of the health domains were significantly reduced. The mental health summary score and the domain mental health score did not differ from the general population. CONCLUSIONS: (1) The method of RRT used in ICU patients with ARF had no influence on survival; (2) The long-term survivors of multi-organ failure have poor physical health.
机译:目的:描述两种肾脏替代疗法(RRT)之一治疗的急性肾功能衰竭和呼吸衰竭患者的长期生活质量,重症监护和医院死亡率。设计:从两种RRT方法的前瞻性观察研究中对长期幸存者进行横断面调查。地点:大学医院内的外科和重症监护室。患者和参与者:126例急性肾功能衰竭和呼吸衰竭患者,需要接受RRT和机械通气治疗。干预措施。 (1)急性肾衰竭的RRT是采用生物相容性膜,前列环素和肝素抗凝(CHDF)进行超滤连续性血液透析或使用铜磷膜和肝素抗凝(IHD)进行间歇性血液透析; (2)使用SF-36(HRQL)问卷评估长期幸存者的健康相关生活质量。测量和主要结果:(1)ICU死亡率(73.5%[39/53] IHD与71.8%[46/64] CHDF,P = NS)或医院死亡率(83%[44/53])没有差异。两个RRT治疗组之间的IHD对比76.5%[49/64] CHDF,P = NS)。到1999年,尚有16名患者幸存。 (2)这些幸存者中有十二人填写了SF-36表格(10 CHDF与2 IHD)。总体身体健康摘要得分和七个健康领域的得分显着降低。精神健康总结分数和领域精神健康分数与普通人群没有差异。结论:(1)ICU ARF患者使用RRT方法对生存无影响; (2)多器官衰竭的长期幸存者身体健康状况较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号